(Q27852024)

2

0 references

F Holst

3

0 references

F Jänicke

4

0 references

V Müller

5

0 references

A Quaas

6

0 references

M Choschzick

7

0 references

W Wilczak

8

0 references

L Terracciano

9

0 references

R Simon

10

0 references

G Sauter

11

0 references

A Lebeau

Breast Cancer Research and Treatment

12

0 references

language of work or name

English

0 references

publication date

February 2013

0 references

published in

0 references

volume

137

0 references

page(s)

745-53

0 references

issue

3

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s10549-013-2406-4

0 references

cites work

Co-activators and co-repressors in the integration of transcriptional responses

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Modulation of estrogen receptor activity by selective coregulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

p300 requires its histone acetyltransferase activity and SRC-1 interaction domain to facilitate thyroid hormone receptor activation in chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Steroid receptor coactivator-1 is a histone acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Amplified in breast cancer 1 in human epidermal growth factor receptor - positive tumors of tamoxifen-treated breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

REporting recommendations for tumor MARKer prognostic studies (REMARK).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Elevated expression levels of NCOA3, TOP1, and TFAP2C in breast tumors as predictors of poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Expression of Sex Steroid Receptors and their Co-Factors in Normal and Malignant Breast Tissue: AIB1 is a Carcinoma-Specific Co-Activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

AIB1 is a predictive factor for tamoxifen response in premenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Expression of AIB1 protein as a prognostic factor in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

AIB1 is required for the acquisition of epithelial growth factor receptor-mediated tamoxifen resistance in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

ACTR/AIB1 functions as an E2F1 coactivator to promote breast cancer cell proliferation and antiestrogen resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

SRC-3/AIB1: transcriptional coactivator in oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Overexpression of an N-terminally truncated isoform of the nuclear receptor coactivator amplified in breast cancer 1 leads to altered proliferation of mammary epithelial cells in transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

The role and regulation of the nuclear receptor co-activator AIB1 in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Cloning of BCAS3 (17q23) and BCAS4 (20q13) genes that undergo amplification, overexpression, and fusion in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4

Adjuvant chemotherapy in luminal breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2406-4